Active Ingredient(s):Abiraterone Acetate FDA Approved: * May 22, 2018 Pharm Company: *SUN PHARMA GLOBAL Category:Cancer
Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog....
* May have multiple approval dates, manufacturers, or labelers.